Arca
Skip to content
Tools
Tools

Liver cirrhosis

Drug research and approvals for liver cirrhosis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 351 studies of liver cirrhosis are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 3 authorised medicines for it.

  • Recruiting worldwide: 351
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 3

Recruiting now

Newest posted first, of 351 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 5

Phase 3 12 of 27

Phase 2 12 of 26

Phase 1 or earlier 12 of 18

How its trials ended

1,546 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 269 whose ending is known, 36% met their primary endpoint, 7% missed it and 56% stopped early.

  • Completed, result not reported51133%
  • Status unknown40226%
  • Ongoing36424%
  • Met its primary endpoint986%
  • Stopped: other or unclear835%
  • Stopped: enrollment or feasibility352%
  • Missed its primary endpoint201%
  • Stopped: sponsor or business decision131%
  • Stopped: lack of efficacy111%
  • Stopped: funding5<1%
  • Stopped: safety4<1%

Medicines authorised in the EU

Newest first
Oct 22, 2026LynavoyLinerixibat · orphanGlaxoSmithKline Trading Services LimitedEMA ↗
Sep 19, 2024IqirvoElafibranor · orphanIpsen PharmaEMA ↗
not availableLyvdelzi (previously Seladelpar Gilead)Seladelpar lysine dihydrate · orphanGilead Sciences Ireland Unlimited CompanyEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.